Loading chart…
PRE-MARKET
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies.
Vimta Labs Limited (VIMTALABS) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The VIMTALABS share price is ₹496.45 (-2.14% today), with a market capitalisation of ₹22B and a price-to-earnings (P/E) ratio of 27.9. MarketRipple tracks the VIMTALABS investment thesis, the ripple-chain impact of market events on Vimta Labs Limited, and the Healthcare sector outlook.
Open
₹505.05
High
₹512.00
Low
₹490.80
Prev. Close
₹507.30
52W High
₹675.00
52W Low
₹376.05
Day range
₹490.80–₹512.00
52-week range
₹376.05–₹675.00
Volume
47K
P/E
27.9
ROE
17.7%
D/E
0.01
Margin
18.6%
Vimta Labs Limited (NSE: VIMTALABS) is currently trading at ₹496.45 (-2.14%).
Vimta Labs Limited's market capitalization is ₹22B.
Vimta Labs Limited's price-to-earnings (P/E) ratio is 27.9.
Vimta Labs Limited operates in the Healthcare sector (Diagnostics & Research).